The company
Revelation Biosciences, Inc.
REVB · Nasdaq
REVB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 53.4% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 36
- Institutions holding
- 10 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
36 disclosed lines: House 0, Senate 36, executive 0; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | soldjoint | $15k–$50k | 31 Jul 2019filed 6 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part of | $15k–$50k | 27 Jul 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $15k–$50k | 27 Jul 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part of | $15k–$50k | 27 Jul 2018filed 3 Aug 2018 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 25 Jun 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part of | $1k–$15k | 25 Jun 2018filed 18 Jul 2018 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $15k–$50k | 6 Jun 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part of | $15k–$50k | 6 Jun 2018filed 18 Jul 2018 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 16 May 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 30 Apr 2018filed 12 Aug 2019 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part of | $1k–$15k | 30 Apr 2018filed 15 May 2018 |
| Patrick J. Toomey Senate: U.S. Senate eFDSenator | sold part ofjoint | $1k–$15k | 22 Mar 2018filed 12 Aug 2019 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| SABBY MANAGEMENT, LLCadded · filed 14 Aug 2026 | 210,582$217K | +111,150+111.8% |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 38,579$40K | +38,579 |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 17,192$18K | -26,003−60.2% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 13,127$14K | 00.0% |
| Tower Research Capital LLC (TRC)added · filed 11 Aug 2026 | 6,528$6,724 | +2,454+60.2% |
| ROYAL BANK OF CANADAunchanged · filed 14 Aug 2026 | 747$1,000 | 00.0% |
| SBI Securities Co., Ltd.unchanged · filed 23 Jul 2026 | 344$354 | 00.0% |
| BARCLAYS PLCnew · filed 14 Aug 2026 | 168$173 | +168 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A.unchanged · filed 13 Aug 2026 | 9$9 | 00.0% |
| Caitong International Asset Management Co., Ltdunchanged · filed 5 Aug 2026 | 1$1 | 00.0% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.